These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Direct immunofluorescence for the study of cutaneous drug eruptions. Gibson LE; van Hale HM; Schroeter AL Acta Derm Venereol; 1986; 66(1):39-44. PubMed ID: 2424213 [TBL] [Abstract][Full Text] [Related]
14. Inpatient adverse cutaneous drug eruptions and eosinophilia. Romagosa R; Kapoor S; Sanders J; Berman B Arch Dermatol; 2001 Apr; 137(4):511-2. PubMed ID: 11295947 [No Abstract] [Full Text] [Related]
16. [Chloroquine-induced cutaneous hyperpigmentation]. Anders HJ; Sperling JH; Schewe S Med Klin (Munich); 2006 May; 101(5):421. PubMed ID: 16685490 [No Abstract] [Full Text] [Related]
17. Adverse cutaneous drug eruptions and HIV: a clinician's global perspective. Todd G Dermatol Clin; 2006 Oct; 24(4):459-72, vi. PubMed ID: 17010776 [TBL] [Abstract][Full Text] [Related]